Regeneron Pharmaceuticals, Inc.

New England Research & Management, Inc. REGN

Report date

6/30/2026

Quarter

2026 Q2

Filed

7/9/2026

Shares

3,475

Value ($000)

2,167

Weight

0.8%

2013 Q4 - 2026 Q2 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	7/9/2026	2,167	0.8%	3,475	6/30/2026
2026 Q1	5/7/2026	444	0.2%	575	3/31/2026
2025 Q4	1/7/2026	386	0.2%	500	12/31/2025
2025 Q2	7/9/2025	318	0.2%	605	6/30/2025
2013 Q4	1/8/2014	688	0.7%	2,498	12/31/2013